Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors purchased 24,073 call options on the stock. This represents an increase of 38% compared to the typical volume of 17,462 call options.
Analyst Ratings Changes
Separately, Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a report on Friday, February 9th.
View Our Latest Stock Analysis on ACB
Aurora Cannabis Trading Down 3.0 %
Aurora Cannabis (NASDAQ:ACB – Get Free Report) last announced its quarterly earnings data on Thursday, February 8th. The company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.10). The business had revenue of $53.34 million during the quarter, compared to the consensus estimate of $45.94 million. Aurora Cannabis had a negative return on equity of 23.27% and a negative net margin of 48.82%. As a group, equities research analysts forecast that Aurora Cannabis will post -0.85 earnings per share for the current year.
Institutional Investors Weigh In On Aurora Cannabis
A number of hedge funds have recently made changes to their positions in the business. MMCAP International Inc. SPC bought a new stake in Aurora Cannabis during the 3rd quarter valued at $4,659,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in Aurora Cannabis by 6.3% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,888,202 shares of the company’s stock valued at $1,690,000 after buying an additional 172,049 shares during the last quarter. Yong Rong HK Asset Management Ltd bought a new stake in Aurora Cannabis during the 3rd quarter valued at $878,000. Cambria Investment Management L.P. raised its holdings in Aurora Cannabis by 115.5% during the 3rd quarter. Cambria Investment Management L.P. now owns 386,365 shares of the company’s stock valued at $226,000 after buying an additional 207,095 shares during the last quarter. Finally, Mackenzie Financial Corp bought a new stake in Aurora Cannabis during the 4th quarter valued at $98,000. 47.63% of the stock is currently owned by institutional investors.
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
- Five stocks we like better than Aurora Cannabis
- 10 Best Airline Stocks to Buy
- High-Yield Texas Instruments Could Hit New Highs Soon
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Profitably Trade Stocks at 52-Week Highs
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.